Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations.

Abstract

The European LeukemiaNet (ELN) genetic risk classifications were developed based on data from younger adults receiving intensive chemotherapy.

Emerging analyses from patients receiving less-intensive therapies prompted a proposal for an ELN genetic risk classification specifically for this patient population.

Article info

Journal issue:

Volume: 144
Issue: 21

Doi:

10.1182/blood.2024025409

More resources:

MedlinePlus Health Information

Medical

Free resource

Silverchair Information Systems

Full Text Sources

Paid